Tetra Radar · FDA Approvals · Decision date

Moderna Inc: FDA decision date

Moderna Inc (MRNA) · 5 August 2026

The FDA has assigned a PDUFA date for mRNA-1010 of August 5, 2026.

Source: 10-Q of 31 July 2026

The FDA approved it on 5 August 2026.

The FDA approved MFLUSIVA for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B represented in the vaccine in persons 50 years of age and older.

Moderna Inc on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.